David P. Hochman, the Chief Executive Officer and Chairperson of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO), recently purchased 5,000 shares of the company's common stock. The shares were acquired at a weighted average price of $4.91 per share, amounting to a total investment of $24,550. This transaction, which occurred on December 18, 2024, increased Hochman's direct ownership to 575,498 shares. The purchase comes as the stock has experienced a notable 11% decline over the past week, with the current market capitalization standing at $181 million. InvestingPro data shows analyst price targets ranging from $14 to $20, suggesting potential upside.
In addition to his direct holdings, Hochman holds shares indirectly through various trusts. These trusts include the DPH 2008 Trust, the Solomon Ascher Hochman 2019 Trust, the Hannah Hochman 2019 Trust, the Judah Herman Hochman 2019 Trust, and the NSH 2008 Family Trust, collectively holding several thousand shares.
This recent acquisition underscores Hochman's ongoing confidence in Orchestra BioMed, a company known for its innovative solutions in the medical instruments and apparatus sector.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.